
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 902 | 902 | 1047 | 1223 | 2658 | 2292 |
Fund Return | -9.77% | -9.77% | 4.73% | 6.95% | 21.6% | 8.65% |
Place in category | 580 | 580 | 212 | 218 | 103 | 36 |
% in Category | 91 | 91 | 31 | 40 | 24 | 15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
KI Midcap Fund B USD Acc | 3.23B | -9.77 | 6.95 | 8.32 | ||
KI Midcap Fund I USD Acc | 3.23B | -9.77 | 7.00 | 8.68 | ||
LU0675383409 | 3.23B | -16.37 | 6.52 | 8.91 | ||
WB US Small Mid Cap Growth Fund Cla | 750.42M | -11.38 | 0.24 | 9.04 | ||
Artemis US Ext Alpha B acc USD | 445.71M | 24.99 | 8.18 | 13.13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HSBC Indian Eq ADHKD | 1.16B | -4.86 | 6.10 | 5.77 | ||
Goldman Sachs India Equity Portfoli | 4.47B | -9.31 | 7.12 | 8.90 | ||
GS India Equity Portfolio Base Acc | 4.47B | -9.40 | 6.58 | 8.29 | ||
GS India Equity Portfolio Base Inc | 4.47B | -9.42 | 6.57 | 8.29 | ||
GS India Equity Portfolio I A Inc | 4.47B | -9.53 | 6.03 | 7.74 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shriram Finance | INE721A01047 | 4.75 | 676.05 | +0.60% | |
Eternal | INE758T01015 | 3.60 | 222.08 | -0.07% | |
Max Healthcare Institute | INE027H01010 | 3.54 | 1,077.50 | +0.32% | |
Apollo Hospitals | INE437A01024 | 3.43 | 7,005.50 | +1.46% | |
Persistent Systems | INE262H01021 | 2.81 | 4,705.50 | -0.22% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | BUY | Strong Sell |
Summary | Strong Buy | Buy | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review